Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non‐small cell lung cancer

BACKGROUND: Cisplatin (CDDP) and vinorelbine as an adjuvant chemotherapy improve the overall survival of patients with completely resected non‐small cell lung cancer (NSCLC). However, the treatment completion rate is low due to severe adverse events (AEs). Pemetrexed (PEM) has been used in advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachihara, Motoko, Dokuni, Ryota, Okuno, Keiko, Tokunaga, Shuntaro, Nakata, Kyosuke, Katsurada, Naoko, Yamamoto, Masatsugu, Nagano, Tatsuya, Kobayashi, Kazuyuki, Tanaka, Yugo, Funada, Yasuhiro, Maniwa, Yoshimasa, Nishimura, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471012/
https://www.ncbi.nlm.nih.gov/pubmed/32729237
http://dx.doi.org/10.1111/1759-7714.13567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471012/
https://www.ncbi.nlm.nih.gov/pubmed/32729237
http://dx.doi.org/10.1111/1759-7714.13567

Ejemplares similares